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1. Introduction 
1.1 What are clinical research/trials? Clinical research has been defined to cover different scopes. Some of the definitions 
are given below. 
The US national institutes of health define clinical research as a patient-oriented 
conducted research system, where either human beings are the subjects or materials are 
subjected to study (Richesson and Andrews, 2012). So the broad areas that are covered 
under this definition include therapeutic investigation, human diseases development 
mechanisms, up-comings of new technology, behavioural studies, epidemiology and even 
health services. 
Clinical research may refer to drug bibliography.  In other words, it involves the 
development of tested articles in the laboratory to the point at which it reaches the 
intended user (consumers in the market.  Once a molecule has been identified in the 
laboratory, its aspects are explored by subjecting it to study (Nichd.nih.gov, 2015). 
Usually, clinical research is carried out at academic centres of medical.    These 
centres offer Prestige of the academic institution and give access to metropolitan.  This has 
availed a pool of volunteers as well as medical participants.  (Keck.usc.edu, 2015). 
 
1.2 What are case-controlled clinical trials? Clinical trials are key in an assessment of the medicine safety and their effectiveness 
(RAVINA, B. 2012).  The major drawback of a clinical trial is that the population sample use 
for the trial may not be a true representation of the entire population.  Therefore, inaccurate 
conclusions may be made. 
Case-control is one of the types of observational studies.  It involves using the cases 
(those with the outcome of the interest) and controls (those without the outcome of 
interest).  The criteria for selecting these categories of the groups should be known and 
made clear.  After the selection, the exposure is administered in the two groups, and the 
correct observation is made.  One of the major advantages of the method is that it is cheap 
and is very useful in conducting research on rare diseases.  The study has an objective of 
relating the exposure and the outcome. 
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According to Porta’s Dictionary of Epidemiology, case-control study is described as 
observational epidemiology in which persons of interest (outcome variable) are studied 
alongside control group (reference group) (Younger, 2009). 
A case-control study is preferred when the disease being studied is rare.  In such a 
case-cohort study is impractical (ROTHMAN, 2008, p.112). 
 
1.3 What is the TNF variant in diabetic nephropathy? 
1.3.1 Entrez Gene summary for TNF Gene     This gene handles encoding pointflammatory cytokine that performs multifunction.  
It performs its operations through the receptors TNNFRSF1B/TNFBR and TNFRSF1A/TNFR1.  
This cytokine regulates some biological processes.  Some of the biologically regulated 
processes include lipid metabolism, apoptosis differentiation and coagulation.  Cytokine is 
implicated in various diseases even in autoimmune diseases, cancer and insulin.  In mice, 
knockout studies, have given a suggestion that cytokine has a neuro-protective function. 
[Provided by RefSeq, Jul 2008]. 
 
Figure 1.1 shows a cytogenetic band. 
 
Figure 1. 1 cytogenetic band (Database, 2015). 
 
1.3.2 GeneCards Summary for TNF Gene  
TNF is protein in nature, and it is a coding gene.  Some of the diseases associated 
with TNF are aphthous stomatitis and mycobacterium chelonae.  Some of its pathways are 
Proteoglycans in cancer and MARK signalling pathway (Database, 2015).  The gene is related 
to GO annotations that include cytokine activity and identical protein binding.  The gene 
important Para log is TNFSF15. 
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1.3.3 UniProtKB/Swiss-Prot for TNF Gene TNFA_HUMAN,P01375 This is a cytokine that binds to TNFRSF1B/TNFBR and TNFRSF1A/TNFR1.  It causes 
fever in either through direct action or stimulation (interleukin-1 secretion is stimulated).  In 
certain conditions, cell proliferation is stimulated, and this leads to induction of cell 
differentiation.  Treg (impairs regulatory T-cells) do function in persons having rheumatoid 
arthritis through FOXP3 dephosphorylation.  Treg cells are rendered functionally defective if 
FOXP3 are inactivated (Database, 2015). 
 
1.3.4 What is STROBE? 
Most researches in the medical field are observational in nature (MAGNUS, M. 2009). 
Therefore, reporting may be of low quality for this reason STROBE statement was developed 
to carb the problem.  The term STROBE stands for strengthening the Reporting of 
Observational Studies in Epidemiology.  STROBE Statement is, therefore, a guideline 
consisting of twenty-two items that are considered to render good reporting in 
observational studies.  Its publications have been done in most biomedical journals for the 
obvious reasons.  Its founder is International Committee of Medical Journal Editors (Strobe-
statement.org, 2015). 
Case-control study, cohort study and cross-sectional study do share eighteen items of 
the STOBE Statement.  Four items are specific to each type of the observational study.  Its 
main objective is to improve reporting quality (Strobe-statement.org, 2015). 
Table 1.1 shows the TROBE statement entailing all the items used in strengthening 
the quality of the report concerning epidemiology. 
 
STROBE Statement—which is a Checklist of items that are included in reports of 
case-control Studies  
 Item 
No 
Recommendation 
Title and abstract 1 (a) Indicate the study’s design with a commonly used term in the title or 
the abstract 
(b) Provide in the abstract an informative and balanced summary of what 
was done and what was found 
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Introduction 
Background/rationale 2 Explain the scientific background and rationale for the investigation being 
reported 
Objectives 3 State specific objectives, including any pre-specified hypotheses 
Methods 
Study design 4 Present key elements of study design early in the paper 
Setting 5 Describe the setting, locations, and relevant dates, including periods of 
recruitment, exposure, follow-up, and data collection 
Participants 6 (a) Give the eligibility criteria, and the sources and methods of case 
ascertainment and control selection.  Give the rationale for the choice of 
cases and controls 
(b) For matched studies, give matching criteria and the number of 
controls per case 
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, 
and effect modifiers.  Give diagnostic criteria, if applicable 
Data sources/ 
measurement 
8* For each variable of interest, give sources of data and details of methods 
of assessment (measurement).  Describe comparability of assessment 
methods if there is more than one group 
Bias 9 Describe any efforts to address potential sources of bias 
Study size 10 Explain how the study size was arrived at 
Quantitative variables 11 Explain how quantitative variables were handled in the analyses.  If 
applicable, describe which groupings were chosen and why 
Statistical methods 12 (a) Describe all statistical methods, including those used to control for 
confounding 
(b) Describe any methods used to examine subgroups and interactions 
(c) Explain how missing data were addressed 
(d) If applicable, explain how matching of cases and controls was 
addressed 
(e) Describe any sensitivity analyses 
Results 
Participants 13* (a) Report numbers of individuals at each stage of study—e.g. numbers 
potentially eligible, examined for eligibility, confirmed eligible, included in 
the study, completing follow-up, and analysed 
(b) Give reasons for non-participation at each stage 
(c) Consider use of a flow diagram 
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Descriptive data 14* (a) Give characteristics of study participants (e.g. demographic, clinical, 
social) and information on exposures and potential confounders 
(b) Indicate number of participants with missing data for each variable of 
interest 
Outcome data 15* Report numbers in each exposure category, or summary measures of 
exposure 
Main results 16 (a) Give unadjusted estimates and, if applicable, confounder-adjusted 
estimates and their precision (e.g., 95% confidence interval).  Make clear 
which confounders were adjusted for and why they were included 
(b) Report category boundaries when continuous variables were 
categorized 
(c) If relevant, consider translating estimates of relative risk into absolute 
risk for a meaningful time period 
Other analyses 17 Report other analyses done—e.g. analyses of subgroups and interactions, 
and sensitivity analyses 
Discussion 
Key results 18 Summarise key results with reference to study objectives 
Limitations 19 Discuss limitations of the study, taking into account sources of potential 
bias or imprecision.  Discuss both direction and magnitude of any 
potential bias 
Interpretation 20 Give a cautious overall interpretation of results considering objectives, 
limitations, multiplicity of analyses, results from similar studies, and other 
relevant evidence 
Generalizability 21 Discuss the generalizability (external validity) of the study results 
Other information 
Funding 22 Give the source of funding and the role of the funders for the present 
study and, if applicable, for the original study on which the present article 
is based 
Table 1. 1 : (STROBE statement: guidelines for reporting observational studies, 2007) 
 
2. Objective 
The objective of this paper is to evaluate/assess, using the STROBE statement 
checklist, the reporting quality of case-controlled trials of the variant TNF in diabetic 
nephropathy.  
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In essence, the researcher will compile a list of case-controlled trial papers and mark, 
or grade them, according to the checklist provided Table 1.1.  Each paper will be examined 
and the researcher will look for the points mentioned in the STROBE statement checklist.  It 
goes without saying that the more points a paper satisfies, the more reliable it can be 
deemed in the eyes of the medical community, as it follows a predetermined set of rules and 
satisfies a series of conditions that make it more medically useful. 
 
3. Methodology 
This analysis is based on a sample of eight reports of case-controlled trials.  The case-
controlled study is based on the topic variant tumour necrosis factor (TNF) in diabetic 
nephropathy.  Eight relevant journal articles  for the study were obtained online.  The 
articles were picked based on relevancy.  Relevancy was checked based on the research 
topic of the article.  The articles picked were analysed by employing the principles of a case-
controlled study; one of the methods of the observational study. 
The STROBE Statement is used as the assessment tool.  Each and every article is read 
and then cross-checked with the STROBE Statement (checklist).  The process of 
crosschecking is done per subtopic as provided by the STROBE Statement.  For example, an 
introduction section of the article is read and verified whether it has a scientific background 
and the rationale of undertaking such a study. 
Marks are awarded to each point stated in the section if that point is a requirement 
of the STROBE Statement.  The distribution of marks is as follows: one mark for every point 
fulfilled, half a mark is awarded for every partially fulfilled point and finally zero for non-
fulfilled point.  The grand score is reached by summing all the marks scored.  Percentage 
calculation is done by the formula shown below: 
 
Where x is the marks awarded to the article.  22 is the total marks that can be 
attained if all the STROBE Statement points are adhered to. 
The process is repeated for the eight articles.  The scores obtained are then grouped 
together according to the scores.  The number of groups required are four, broken down 
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into 4 tiers, based on score percentage.  These tiers are 0.00-24.99%, 25.00-49.99%, 50.00-
74.99% and 75.00-100%.  All percentages are calculated using the aforementioned formula, 
by inputting the score obtained after assessing each article using the STROBE statement. 
Once the grouping is done the process of analysis commences.  If the percentage 
scored by the majority of articles is high, then the STROBE statement has high quality for 
case-controlled study.  On the other hand, if the marks scored by the majority of articles is 
low, then the quality of the STROBE statement may be considered to be low. 
 
4. Results The seven articles have been analysed as stated in the methodology.  Tables are used 
to ease the analysis.  Explanations are provided within the tables.  Each article has its own 
table.  The name of the article is used as the name of the table. 
 
4.1 Genetics of diabetic nephropathy (Lee et al., 2005). 
Item 
No 
Item Remarks  Score 
Title and 
abstract 
1 Title and 
abstract 
The term diabetic nephropathy, which appears in the 
title, is the study’s design. 
1 
Task performed and results found are described in 
the abstract.  Hence the abstract is a balanced 
summary and informative. 
Introduction 2 Background  Scientific definition of diabetic nephropathy is given 
and other additional scientific information is 
provided.  So scientific background is fully satisfied. 
The rationale of the study is provided. 
1 
 3 Objectives The study aims at providing conclusive results on the 
research subjects (Lee et al., 2005).  Therefore, 
clarity in specific objectives. 
1 
Methods  4 Study design Key elements are availed early and they are as 
follows: 
TNF-alpha -308G/A 
Polymorphism 
Gene 
1 
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Diabetic nephropathy 
Meta-analysis 
5 Setting  Location-provided e.g. Cochrane Library. 
Relevant dates-provided e.g. March 10, 2013- last 
search date. 
1 
6 Participants  Selection criteria availed and the rationale for 
following such criteria. 
1 
Matched studies-not applicable for this case. 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Well stated. 1 
9 Bias  Analyzed through visual inspection 1 
10 Study size Study size is stated. 1 
11 Quantitative 
variables 
Very clear. 1 
12 Statistical 
methods 
All statistical methods are adhered to e.g. use of z-
test, analysis of sensitivity among others. 
1 
Results  13 Participant  At every stage the study size is provided. 
Reasons for disqualification are given 
Flow diagram is used in showing the study size at 
every stage and providing reasons for the 
disqualification. 
1 
14 Descriptive data Clinical participant  
Missing data not stated. 
1 
 15 Outcome data Outcome data-provided. 1 
16 Main results Precision of 95% CI is used; relative risk to absolute 
risk -not applicable for this case; category 
boundaries-not applicable for this case. 
1 
17 Other analysis Both subgroups and sensitivity are analyzed 1 
Discussion  18 Key results Results are given in line with the objectives. 1 
19 Limitations Stated e.g. only two ethnic groups were used so it 
may only be applicable to those groups (Lee et al., 
2005). 
1 
20 Interpretation  Provided as per the requirement. 1 
21 Generalizability  External validity-provided. 1 
Other 22 Source of Not mentioned. 0 
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information funding and 
their role 
 Grand score 21 
Table 4. 1 Article of Genetics of diabetic nephropathy (Lee et al., 2005) 
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4.2 Journal of Diabetes and Its Complications (Gupta et al., 2015).  
Item 
No. 
Item Remarks  Score 
Title and 
abstract 
1 Title and 
abstract 
The term diabetes, which appears in the title, is the 
study’s design. 
Task performed and results found are described in 
the abstract.  The abstract constitutes a balanced 
and informative summary. 
1 
Introduction 2 Background  Chronic kidney disease is described as a world health 
problem (Gupta et al., 2015); and more information 
and scientific background is provided. 
1 
3 Objectives Polymorphisms might play a crucial role in the 
pathogenesis and development of DN (Gupta et al., 
2015).  The above hypothesis is provided. 
1 
Methods  4 Study design Absence of key elements early in the paper. 0 
5 Setting  Locations indicated e.g. Bahadur Hospital 
Relevant dates: starting time of study provided as 
October 2010 and completion time provided as April 
2012 (Gupta et al., 2015). 
1 
6 Participants  Selection criteria availed e.g. group II: patients with 
T2DM for greater or equal 10 years without 
nephropathy (DM) (Gupta et al., 2015). 
Matched studies-not applicable. 
1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Not analyzed. 0 
10 Study size Study size of 300 subjects used. 1 
11 Quantitative 
variables 
Very clear.  
Three groupings were made. 
1 
12 Statistical 
methods 
All statistical methods are adhered to e.g. use of t-
test. 
1 
Results  13 Participant  Study size is provided at the beginning of the study. 0.5 
14 Descriptive data Both demographic (since sex and age are included) 
and clinical participant  
Missing data not mentioned. 
0.5 
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15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
17 Other analysis No analysis of subgroups and sensitivity. 0 
Discussion  18 Key results Not clear. 0.5 
19 Limitations  Stated large sample is required to justify the 
feasibility of the polymorphisms (Gupta et al., 2015). 
1 
20 Interpretation  Provided. 1 
21 Generalizability External validity-provided. 1 
Other 
information 
22 Source of 
funding and 
their role 
Indian Council of Medical Research and University 
College of Medical Sciences, New Delhi (Gupta et al., 
2015).  They supported the research partially. 
1 
 Grand score 18.5 
Table 4. 2 Journal of diabetes and its complications (Gupta et al., 2015) 
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4.3 Association of of TGFβ1, TNFα, CCR2 and CCR5 gene polymorphisms (Prasad et al., 2007). 
Item 
No. 
Item Remarks Score 
Title and 
abstract 
1 Title and 
abstract 
The term Association, which appears in the title, is 
the study’s design. 
Task performed and results found are described in 
the abstract.  The abstract constitutes a balanced 
and informative summary. 
1 
 
Introduction 2 Background  Diabetes type 2 is described in the background; more 
is provided and so is scientific background. 
1 
3 Objectives Association of TGFβ1, TNFα, CCR2 and CCR5 gene 
polymorphisms in type-2 diabetes and renal 
insufficiency among Asian Indians (Prasad et al., 
2007).  The above objective is provided. 
1 
Methods  4 Study design Key elements: 
Cytokines 
Diabetes mellitus 
Diabetic nephropathy 
Inflammation 
Mononuclear cells 
Are provided early in the paper of concern. 
1 
5 Setting  Locations clear. 
Relevant dates mentioned. 
1 
6 Participants  Selection criteria availed. 
Matched studies-not applicable. 
1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Not analyzed. 0 
10 Study size Study size not clear, though implied through mention 
of trial sites (Prasad et al., 2007). 
1 
11 Quantitative 
variables 
Clear. 1 
12 Statistical 
methods 
Statistical methods are adhered to e.g. use of t-test. 1 
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Results  13 Participant  Study size is not provided clearly at every stage of 
the study. 
0.5 
14 Descriptive data Demographic data provided in the background in the 
paper. 
Missing data not mentioned. 
0.5 
15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
17 Other analysis There is analysis of sensitivity. 1 
Discussion  18 Key results Not clear. 0.5 
19 Limitations  Limited to population that provided the sample. 1 
20 Interpretation  Provided. 1 
21 Generalizability  Outcome not clearly generalized, because it is not 
mentioned whether the results obtained would 
extend to other population outside the population 
sample. 
0.5 
Other 
information 
22 Source of 
funding and 
their role 
Not mentioned. 0 
 Grand score 18.0 
Table 4. 3 Association of of TGFβ1, TNFα, CCR2 and CCR5 gene polymorphisms 
(Prasad et al., 2007) 
 
 
 
 
 
 
 
 
 
 
 
Institutional Repository - Library & Information Centre - University of Thessaly
09/12/2017 13:11:35 EET - 137.108.70.7
 
UNIVERSITY OF THESSALY, MEDICAL SCHOOL OF LARISSA Methodology of Biomedical Research, Biostatistics and Clinical Bioinformatics 
 
Assess the reporting quality of case-controlled trials of the variant TNF in diabetic nephropathy, based on STROBE statement 18  
4.4 Association between LTA, TNF and AGER Polymorphisms and Late Diabetic Complications (Lindholm et al., 2008). 
Item 
No. 
Item Remarks Score 
Title and 
abstract 
1 Title and 
abstract 
The terms Association and polymorphisms, which 
appear in the title, is the study’s design. 
Activities performed and results found are described 
in the abstract.  Hence the abstract is balanced and 
informative summary. 
1 
 
Introduction 2 Background  Has scientific background due to description of 
scientific terms like polymorphisms and 
complications, among others. 
1 
3 Objectives The aim of this study is to seek an association 
between LTA, TNF and AGER Polymorphisms and 
Late Diabetic Complications, through analysis of 
results.(Lindholm et al., 2008). 
1 
Methods  4 Study design Key elements: 
Association 
LTA 
TNF 
AGER polymorphisms 
Provided early in the paper of concern. 
1 
5 Setting  Locations not provided. 
Relevant dates not mentioned. 
0 
6 Participants  Selection criteria made available. 1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Mentioned but not analyzed. 0.5 
10 Study size Study size mentioned. 1 
11 Quantitative 
variables 
Clear. 1 
12 Statistical 
methods 
Statistical methods are adhered to e.g. use of t-test. 1 
Results  13 Participant  Study size is provided at every stage of the study. 1 
14 Descriptive data Demographic and clinical 0.5 
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Missing data not mentioned. 
15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
17 Other analysis Sensitivity is analyzed. 1 
Discussion  18 Key results Clear. 1 
19 Limitations  Small sample of type 1 diabetic patients, which could 
lead to misrepresentation (Lindholm et al., 2008). 
1 
20 Interpretation  Provided. 1 
21 Generalizability  Made clearly. 1
Other 
information 
22 Source of 
funding and 
their role 
Mentioned in the acknowledgements of the assessed 
paper. 
1 
 Grand score 19.0 
Table 4. 4 Association between LTA, TNF and AGER Polymorphisms and Late Diabetic 
Complications (Lindholm et al., 2008) 
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4.5 Association of interleukin-10 polymorphisms with cytokines in type 2 diabetic nephropathy. (Kung et al., 2010). 
Item 
No. 
Item Remarks Score 
Title and 
abstract 
1 Title and 
abstract 
The terms association and polymorphisms, which 
appear in the title, is the study’s design. 
Abstract provides activities performed and results 
obtained hence it is very informative and balanced.   
1 
 
Introduction 2 Background  Description of scientific terms like interleukin-10 
polymorphism is made (Kung et al., 2010).  Hence, 
scientific background. 
1 
3 Objectives Aim of this study is to seek an association of 
interleukin-10 polymorphisms with cytokines in type 
2 diabetic nephropathy (Kung et al., 2010). 
1 
Methods  4 Study design Key elements were presented earlier in the paper. 1 
5 Setting  The setting is menioned (Taiwan) 
Relevant dates are also mentioned. 
1 
6 Participants  Selection criteria availed-selection from patient pool 
(Kung et al., 2010). 
1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Analysed. 1 
10 Study size Study size is clearly stated (Kung et al., 2010). 1 
11 Quantitative 
variables 
Clear. 1 
12 Statistical 
methods 
Statistical methods are adhered to e.g. use of logistic 
regression analysis (Gruden et al., 2012). 
1 
Results  13 Participant  Study size is provided at every stage of the study. 1 
14 Descriptive data Demographic and clinical 
Missing data not mentioned. 
0.5 
15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
17 Other analysis Sensitivity is analysed. 1 
Discussion  18 Key results Not clear. 0.5 
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19 Limitations  Miscalculation of case subjects and controls could 
have led to errors (Kung et al., 2010). 
1 
20 Interpretation  Provided. 1 
21 Generalizability  Made clear. 1 
Other 
information 
22 Source of 
funding and 
their role 
Not mentioned. 0 
 Grand score 20.0 
Table 4. 5 Article on the Association of interleukin-10 polymorphisms with cytokines in 
type 2 diabetic nephropathy. (Kung et al., 2010) 
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4.6 Gene (Dabhi and Mistry, 2015) 
Item 
No. 
Item Remarks Score 
Title and 
abstract 
1 Title and 
abstract 
The term gene, which appears in the title, is the 
study’s design. 
Abstract provides activities performed and results 
obtained hence it is very informative and balanced.  
1 
 
Introduction 2 Background  Description of scientific terms like diabetic 
nephropathy is made; and more other scientific 
description.  Hence, scientific background. 
1 
3 Objectives The aim of this study is to understand the role of 
cytokine gene polymorphism and oxidative stress on 
pathophysiology of diabetes and on the onset of 
secondary complications (Dabhi and Mistry, 2015). 
1 
Methods  4 Study design Key elements: 
TNF-α gene polymorphism 
IL-1α gene polymorphism  
Diabetes  
Diabetic nephropathy  
Oxidative stress  
West Indian population 
Presented earlier in the paper. 
1 
5 Setting  Locations West Indian 
Relevant dates not mentioned. 
0.5 
6 Participants  Selection criteria availed. 1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Not analysed. 0 
10 Study size Study size provided with a control group of 235. 1 
11 Quantitative 
variables 
Clear. 1 
12 Statistical 
methods 
Statistical methods are adhered to e.g. use of chi-
test. 
1 
Results  13 Participant  Study size is provided. 0.5 
14 Descriptive data Demographic and clinical (evidenced by table 1) 0.5 
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Missing data not mentioned. 
15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
17 Other analysis Sensitivity is not analysed. 0 
Discussion  18 Key results Not clear. 0.5 
19 Limitations  Not clear. 0.5 
20 Interpretation  Provided. 1 
21 Generalizability  Made clearly. 1 
Other 
information 
22 Source of 
funding and 
their role 
Mentioned e.g Charutar Vidya Mandal (Dabhi and 
Mistry, 2015).  
1 
 Grand score 17.0 
Table 4. 6 Article of Gene (Dabhi and Mistry, 2015)  
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4.7 Genetic Determination of TNF and Myeloperoxidase Production in Dialyzed Patients with Diabetic Nephropathy (Buraczynska et al., 2004). 
Item 
No. 
Item Remarks Score 
Title and 
abstract 
1 Title and 
abstract 
The term genetic determination, which appears in 
the title, is the study’s design. 
Abstract provides activities performed and results 
obtained are very informative and balanced. 
1 
 
Introduction 2 Background  Description of scientific terms like Myeloperoxidase 
Production, are made clear in the introduction; and 
further scientific description.  Hence, scientific 
background. 
1 
3 Objectives The aim of this study is to determine the genetic 
makeup of TNF and Myeloperoxidase Production in 
Dialyzed Patients with Diabetic Nephropathy 
(Buraczynska et al., 2004). 
1 
Methods  4 Study design Key elements presented earlier in the paper. 1 
5 Setting  Locations: Hospital of the researchers 
Relevant dates mentioned in the paper (Buraczynska 
et al., 2004). 
1 
6 Participants  Selection criteria availed. 1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Not analysed. 0 
10 Study size Study size provided. 1 
11 Quantitative 
variables 
Clear. 1 
12 Statistical 
methods 
Statistical methods are adhered. 1 
Results  13 Participant  Study size is provided. 1 
14 Descriptive data Demographic and clinical  
Missing data not mentioned. 
0.5 
15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
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17 Other analysis Sensitivity is partially analysed. 0.5 
Discussion  18 Key results Made clear. 1 
19 Limitations  Made clear. 1 
20 Interpretation  Provided. 1 
21 Generalizability  Made clear. 1 
Other 
information 
22 Source of 
funding and 
their role 
Mentioned in the acknowledgement  1 
 Total score 20.0 
Table 4. 7 Genetic Determination of TNF and Myeloperoxidase Production in Dialyzed 
Patients with Diabetic Nephropathy (Buraczynska et al., 2004). 
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4.8 Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease (Babel et al., 2006). 
Item 
No. 
Item Remarks Score 
Title and 
abstract 
1 Title and 
abstract 
The term predictive value, which appears in the title, 
is the study’s design. 
Abstract provides activities performed and results 
obtained are very informative and balanced. 
1 
 
Introduction 2 Background  Description of scientific terms like cytokine gene 
polymorphisms, are made clear in the introduction; 
and further scientific description.  Hence, scientific 
background. 
1 
3 Objectives The aim of this study is to determine the  
predictive value of cytokine gene polymorphisms for 
the development of end-stage renal disease. (Babel 
et al., 2006). 
1 
Methods  4 Study design Key elements presented earlier in the paper. 1 
5 Setting  Locations: Hospital of the researchers 
Relevant dates mentioned in the paper (Babel et al., 
2006). 
1 
6 Participants  Selection criteria availed. 1 
7 Variables  Outcomes and predictors are clearly defined. 1 
8 Data sources & 
measurements 
Clearly stated. 1 
9 Bias  Mentioned but not analyzed. 0.5 
10 Study size Study size provided. 1 
11 Quantitative 
variables 
Clear. 1 
12 Statistical 
methods 
Statistical methods are adhered. 1 
Results  13 Participant  Study size is provided. 1 
14 Descriptive data Demographic and clinical  
Missing data not mentioned. 
0.5 
15 Outcome data Outcome data-provided. 1 
16 Main results Unadjusted estimates and adjusted estimates are 
provided. 
1 
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17 Other analysis Sensitivity is fully analysed. 1 
Discussion  18 Key results Made clear. 1 
19 Limitations  Made clear. 1 
20 Interpretation  Provided. 1 
21 Generalizability  Made clear. 1 
Other 
information 
22 Source of 
funding and 
their role 
Mentioned in the acknowledgement  1 
 Total score 21.0 
Table 4. 8 Predictive value of cytokine gene polymorphisms for the development of 
end-stage renal disease (Babel et al., 2006). 
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5. Discussion 
The results obtained can be summarised in the table below. 
No. Name of article Raw marks 
scored 
Calculation  Percentage (%) 
1 Genetics of diabetic nephropathy (Lee et 
al., 2005). 
21.0 (21/22)*100 95,45 
2 Journal of Diabetes and Its Complications 
(Gupta et al., 2015). 
18.5 (18.5/22)*100 84,09 
3 Association of of TGFβ1, TNFα, CCR2 and 
CCR5 gene polymorphisms (Prasad et al., 
2007). 
18.0 (18.0/22)*100 81,81 
4 Association between LTA, TNF and AGER 
Polymorphisms and Late Diabetic 
Complications (Lindholm et al., 2008). 
19.0 (19./22)*100 86,36 
5 Association of interleukin-10 
polymorphisms with cytokines in type 2 
diabetic nephropathy. (Kung et al., 2010). 
20 (20/22)*100 90,90 
6 Gene (Dabhi and Mistry, 2015) 17.0 (17.0/22)*100 77,27 
7 Genetic Determination of TNF and 
Myeloperoxidase Production in Dialyzed 
Patients with Diabetic Nephropathy 
(Buraczynska et al., 2004). 
20.0 (20.0/22)*100 90,90 
8 Predictive value of cytokine gene 
polymorphisms for the development of 
end-stage renal disease (Babel et al., 
2006). 
21.0 (21/22)*100 95,45 
Table 5. 1 Results in summary 
 
The results are grouped as shown in the table below for the purpose of analysis. 
Grouping of data 0.00-24.99% 25.00-49.99% 50.00-74.99% 75.00-100% 
Number of articles (frequency) 0 0 0 8 
Table 5. 2 Grouped data 
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From the table of grouped data it is well depicted that all the journal articles analysed 
by the STROBE statement (checklist) lie in the fourth group of the table i.e. they have scores 
of 75% and above with half of the articles found to have scores over 90%. 
Therefore, a general deduction can be made.  The STROBE Statement has high 
reporting quality in case-controlled studies, as most of the articles that were assessed, 
satisfied the majority of the points on the STROBE checklist.  Nonetheless, the deductions 
would have been much more reliable if a large sample population was analysed.  The only 
limitations for analysing large sample populations is that it is time consuming since each 
article must be read and cross-checked with the STROBE Statement. 
It is also important to reach a conclusion on the quality of the articles assessed.  All 
eight articles, tend to converge towards a common point, i.e. they are nearly homogeneous 
in their findings.  Since almost all of them state that there is no clear relationship between 
the TNF variant and diabetic nephropathy.  But suggestions are made for further 
investigation to include a larger sample population, which can provide us with a clear 
representation as to the event rate in the general population.  Therefore, it can be deduced 
that the articles assessed are of high quality because firstly their findings tend to converge at 
a point and secondly, they meet most requirements set forth in the STROBE statement. 
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